protein structures of SARS-CoV-2

COVID-19 Research Goes Public through New Portal

Tuesday, May 19, 2020
To help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, LLNL has launched a searchable data portal to share its COVID-19 research with scientists and the public.